<!-- ----------------------------------------------------------------- -->
# Chapter 6/Paper 4 {background-color="#fff0a2"}
Improving the spatial and temporal resolution of burden of disease measures with Bayesian models
![](imgs/pillars_p4.png){width=80%}

<!-- ----------------------------------------------------------------- -->
## Under review at *Spatial and Spatio-temporal Epidemiology*
<br>
**James Hogg**, K. Staples, A. Davis, S. Cramb, C. Patterson, L. Kirkland, M. Gourley, J. Xiao, W. Sun. Improving the spatial and temporal resolution of burden of disease measures with Bayesian models.
<br>
<br>
<div class="small-text">**Status**: <span class="blB">Second round</span> of revisions</div
<br>
<br>
<div class="small-text">Partnership with the **Department of Health Western Australia** and the **Australian Institute of Health and Welfare**</span></div

<!-- ----------------------------------------------------------------- -->
## Background {.smaller}

::::: {.columns}

:::: {.column width="68%"}

::: {.incremental}
- BOD estimates $\to$ identify diseases causing excess burden <span class="small-text">[@Murray1997; @GBD2016;@Schmidt2020; @RN121; @Steel2018]</span>
- Disability-adjusted life years (<span class="blB">DALY</span>)
  - Linear and non-linear combinations of <span class="blB">fatal</span> (e.g., mortality) and <span class="blB">non-fatal</span> (e.g., prevalence) burden
  - Fatal component $=$ ‚Äòyears of life lost‚Äô (<span class="blB">YLL</span>)
  - Non-fatal component $=$ ‚Äòyears lived with disability‚Äô (<span class="blB">YLD</span>)
:::
::::

:::: {.column width="28%"}
![](imgs/chp6/bod.webp){width=100% .soft-edges}

::::

:::::

<!-- ----------------------------------------------------------------- -->
## Full BOD studies {.smaller}

::: {.incremental}
- Aim to calculate DALYs for <span class="blB">all</span> causes (typically over 200)
- Prioritise healthcare resources by <span class="blB">ranking diseases</span>
![](imgs/chp6/gbd.png){width=100% .soft-edges}
- **Wide range** of data sources (e.g., registry, administrative, survey or epidemiological)
- Conducted by **government agencies** in Australia
:::

::: {.notes}
Limitation of these data for small area estimates is small counts or gaps (poor reach). SAE can help in this case. 
:::

<!-- ----------------------------------------------------------------- -->
## {auto-animate=true}

::: {style="margin-top: 100px;"}
**Gaps**
:::

<!-- ----------------------------------------------------------------- -->
## {.smaller auto-animate=true}

::: {style="margin-top: 200px; font-size: 3em; color: red;"}
**Gaps**
:::

::: {.incremental}
- <span class="blR">Few</span> studies use Bayesian models <span class="small-text">[@Steel2018; @GBD2015; @CODEm; @RN652; @RN653]</span>
	- <span class="blR">Not</span> applicable to full scope of data
	- <span class="blR">No</span> use of small area estimation methods
	- <span class="blR">Not practical</span> for many users (e.g., government)
- **Australian** full BOD studies
	- <span class="blR">No use</span> of Bayesian models and <span class="blR">no</span> small area estimates
:::

::: {.notes}
Not practical both in terms of applying the methods and interpretation/reconcilling the output.
Once these hurdles have been cleared, Bayesian models, of course, offer considerable advantages. 

The reason for a lack of small area estimates is, in some cases, related to data not being specific enough. In this case, no amount of modelling can help. When survey data has poor reach, Bayesian models can help to fill in the gaps.  
:::

<!-- ----------------------------------------------------------------- -->
## {.center}

::: {.quote-box}
**Contribution** üéâ

A principled and practical set of <span class="blB">Bayesian spatiotemporal methods</span> for modelling the wide range of data in **full BOD studies**.
:::

<!-- ----------------------------------------------------------------- -->
## {.center background-color="#fff0a2"}

::: {.center style="font-size: 0.7em"}
*Thesis aim*
:::

::: {.center style="font-size: 1.5em"}
Develop and apply Bayesian small area methods to health data in Australia
:::

<br>
<br>

::: {.center style="font-size: 0.7em"}
üëâ **Sparsity issues**

üëâ **Improve spatial resolution**

üëâ **Support informed decision making**
:::

<!-- ----------------------------------------------------------------- -->
## Models

::: {.fragment}
- **Intentionally** simple $\to$ <span class="blB">accessible</span> and <span class="blB">practical</span> 
:::

::: {.fragment}
- **Novelty**
	- Not in the <span class="blR">development</span> of new Bayesian models
	- <span class="blB">Application</span> of existing models to the field of BOD
:::

<!-- ----------------------------------------------------------------- -->
## Models {.smaller}

<span class="blB">Standard age-year-time (SAYT) model</span> 

::::: {.columns}

:::: {.column width="28%"}
![](imgs/chp6/disease.webp){width=100% .soft-edges}

::::

:::: {.column width="68%"}

::: {.incremental}
- Model details:
	- **Poisson model**
	- Population as offset
	- Spatial, temporal and space-time **random effects**
- Input data: 
	- **Aggregated counts** by area, year, age, and sex
- Output data: 
	- **Smoothed counts** for each area, year, age, and sex

- Applicable to:
	- **Mortality** or **prevalence** counts
:::
::::

:::::

<!-- ----------------------------------------------------------------- -->
## Models {.smaller}

<span class="blB">Weighted multilevel regression and poststratification (MrP)</span>
<br>
**First use** of small area estimation in BOD

::::: {.columns}

:::: {.column width="28%"}

![](imgs/chp6/mrp.webp){width=100% .soft-edges}
::::

:::: {.column width="68%"}

::: {.incremental}
- Model details:
	- **Logistic model** with poststratification step [@Park2004]
	- **Pseudo-likelihood** [@Savitsky2016]
	- Spatial and temporal **random effects**
- Input data: **Individual level data**
- Output data: **Probabilities** for all combinations of area, year, age, and sex
- Applicable to:
	- **Survey microdata**
:::
::::

:::::

::: {.notes}
"Pseudo likelihood was used in our small area modelling in Chapter 3."

"By modelling microdata, we can improve the reach of estimates from survey data, which tackles a core data limitation in full BOD studies."
:::

<!-- ----------------------------------------------------------------- -->
## Case study {.smaller}

::: {.incremental}
- Data was supplied by Department of Health Western Australia (<span class="blB">DOHWA</span>)
- Two conditions: <span class="blB">Asthma</span> and coronary heart disease (<span class="blB">CHD</span>)
- Geographic: <span class="blB">Local Government Areas</span> (n = 137) in Western Australia
- Time: <span class="blB">2015 to 2020</span> inclusive
- Used <span class="blB">fully Bayesian methods</span> with the statistical software package, $\texttt{nimble}$ [@RN626]
:::

<!-- ----------------------------------------------------------------- -->
## Objective

::: {.incremental}
1. Produce <span class="blB">modelled estimates</span> of:
	i) Mortality and age-standardised 'years of life lost‚Äô (ASYLLs)
	ii) Prevalence/proportions and age-standardised ‚Äòyears lived with disability‚Äô (ASYLDs)
2. <span class="blB">Compare</span> to raw results (i.e., no modelling)
:::

<!-- ----------------------------------------------------------------- -->
## {.center}

<figure style="position: relative; display: block; margin-left: auto; margin-right: auto; text-align: center;">
  ![](imgs/chp6/compraw_ALL_justMeasures.jpeg){height='500px'}
  <figcaption style="text-align: center;">Comparison of the distribution of the point estimates from the Bayesian models and basic stratification (i.e., raw).</figcaption>
</figure>

<!-- ----------------------------------------------------------------- -->
## {.center}

<figure style="position: relative; display: block; margin-left: auto; margin-right: auto; text-align: center;">
  ![](imgs/chp6/compraw_ALL_justMeasures.jpeg){height='500px'}
   <div class="highlight-box" style="position: absolute; top: 0px; left: 288px; width: 245px; height: 240px;"></div>
  <figcaption style="text-align: center;">Comparison of the distribution of the point estimates from the Bayesian models and basic stratification (i.e., raw).</figcaption>
</figure>

<!-- ----------------------------------------------------------------- -->
## {.center}

<figure style="position: relative; display: block; margin-left: auto; margin-right: auto; text-align: center;">
  ![](imgs/chp6/compraw_ALL_justBOD.jpeg){height='500px'}
  <figcaption style="text-align: center;">Comparison of the distribution of the point estimates from the Bayesian models and basic stratification (i.e., raw).</figcaption>
</figure>

<!-- ----------------------------------------------------------------- -->
## {.center}

<figure style="position: relative; display: block; margin-left: auto; margin-right: auto; text-align: center;">
  ![](imgs/chp6/compraw_ALL_justBOD.jpeg){height='500px'}
  <div class="highlight-box" style="position: absolute; top: 0px; right: 275px; width: 228px; height: 245px;"></div>
  <figcaption style="text-align: center;">Comparison of the distribution of the point estimates from the Bayesian models and basic stratification (i.e., raw).</figcaption>
</figure>

<!-- ----------------------------------------------------------------- -->
## {.center}

<figure style="position: relative; display: inline-block;">
  ![](imgs/chp6/results.png){width='880px'}
  <div class="cover-box" style="position: absolute; top: 318px; left: 0px; width: 880px; height: 232px;"></div>
  <figcaption>Comparison of the 822 annual LGA point estimates and their reliability (% of RSEs less than 50%) for modeled and raw BOD measures by condition.</figcaption>
</figure>

<!-- ----------------------------------------------------------------- -->
## {.center}

<figure style="position: relative; display: inline-block;">
  ![](imgs/chp6/results.png){width='880px'}
  <div class="cover-box" style="position: absolute; top: 318px; left: 0px; width: 880px; height: 232px;"></div>
  <div class="highlight-box" style="position: absolute; top: 190px; left: 110px; width: 750px; height: 48px;"></div>
  <figcaption>Comparison of the 822 annual LGA point estimates and their reliability (% of RSEs less than 50%) for modeled and raw BOD measures by condition.</figcaption>
</figure>

<!-- ----------------------------------------------------------------- -->
## {.center}

<figure style="position: relative; display: inline-block;">
  ![](imgs/chp6/results.png){width='880px'}
  <figcaption>Comparison of the 822 annual LGA point estimates and their reliability (% of RSEs less than 50%) for modeled and raw BOD measures by condition.</figcaption>
</figure>

<!-- ----------------------------------------------------------------- -->
## {.center}

<figure style="position: relative; display: inline-block;">
  ![](imgs/chp6/results.png){width='880px'}
  <!-- <div class="highlight-box" style="position: absolute; top: 0px; left: 0px; width: 10px; height: 10px;"></div>
  <div class="highlight-box" style="position: absolute; top: 0px; left: 0px; width: 50px; height: 50px;"></div>
  <div class="highlight-box" style="position: absolute; top: 0px; left: 0px; width: 100px; height: 100px;"></div> -->
  <div class="highlight-box" style="position: absolute; top: 350px; left: 110px; width: 750px; height: 48px;"></div>
  <figcaption>Comparison of the 822 annual LGA point estimates and their reliability (% of RSEs less than 50%) for modeled and raw BOD measures by condition.</figcaption>
</figure>

<!-- ----------------------------------------------------------------- -->
## {.center}

<figure style="position: relative; display: inline-block;">
  ![](imgs/chp6/results.png){width='880px'}
  <div class="highlight-box" style="position: absolute; top: 440px; left: 110px; width: 750px; height: 70px;"></div>
  <figcaption>Comparison of the 822 annual LGA point estimates and their reliability (% of RSEs less than 50%) for modeled and raw BOD measures by condition.</figcaption>
</figure>

<!-- ----------------------------------------------------------------- -->
## {.smaller background-color="#ffffff"}

:::: {.finding-box}
**Key findings** üì¢

::: {.incremental}
- <span class="blB">Bayesian models</span> $\to$ increased the *reliability, certainty and reportability* of estimates
<!-- - Demonstrated **feasibility** of incorporating spatio-temporal models into <span class="blB">full BOD studies</span>
  - Provide **ranks** for disease burden from **all** causes by **small areas** -->
- Bayesian vs. raw: 
	- <span class="blB">Agreed</span> (mostly!)
  - Discrepancies due to <span class="blB">age-standardisation</span> OR <span class="blB">paradigm differences</span> ^[Raw estimates: unstable observed data. Bayesian estimates: smoothed version of the underlying risk.]
:::

::::

<!-- ----------------------------------------------------------------- -->
## Objective 3 {.smaller}

<span class="blB">Burden of disease</span>

‚ùï **3.1 Method:** Explore and develop appropriate Bayesian spatiotemporal methods to model the wide range of health data used in full BOD studies.

‚ùï **3.2 Application:** Using two very different diseases ^[Coronary heart disease (CHD) and asthma in Western Australia], generate and map the first small area level BOD estimates in Australia.

<!-- ----------------------------------------------------------------- -->
## Objective 3 {.smaller}

<span class="blB">Burden of disease</span>

‚úÖ **3.1 Method:** 

‚úÖ **3.2 Application:**